Combined serotonin (5HT2) and dopamine (D2) receptor antagonist. Prepn: E. J. Warawa, B. M. Migler, EP 240228; eidem, US 4879288 (1987, 1989 both to ICI). HPLC and GC/MS determn in plasma: R. H. Pullen et al., J. Chromatogr. 573, 49 (1992). Series of articles on pharmacology: Psychopharmacology 112, 285-307 (1993). Clinical evaluation in schizophrenia: H. Wetzel et al., ibid. 119, 231 (1995). Review of clinical experience: B. Green, Curr. Med. Res. Opin. 15, 145-151 (1999).
Antipsychotic.
Antipsychotic; Other Tricyclics; Serotonin-Dopamine Antagonist